You just read:

Frost & Sullivan: Strong Pipeline of Monoclonal Antibodies (mAbs) Biosimilars in the US and Europe Lends Impetus to Global Market

News provided by

Frost & Sullivan

Jan 29, 2014, 06:51 EST